2006-09-01

fen on the human female genital tract: review of the paring the Cavaterm and the Novasure endometrial Munro MG Review article; Endometrial ablation.

Download Citation | Cavaterm thermal balloon ablation | The Cavaterm plus system consists of two major components - a balloon catheter (Figure 19.1) and a central unit (Figure 19.2). The length of 2020-01-04 "Read about the experiences of people who have received catheter ablation for atrial fibrillation (AF). You’ll learn firsthand what life was like for these particular patients, both before and after their procedure. CONCLUSION (S): Both the Cavaterm and the Novasure endometrial ablation systems are effective in reducing menstrual loss in women with DUB and achieve high rates of patient satisfaction. The Novasure system achieved a statistically significantly higher rate of amenorrhea in this study.

Cavaterm ablation reviews

24 At 12 months, the rate of amenorrhea in the Cavaterm treatment arm was significantly 2003-07-01 Both the Cavaterm ™ and the Novasure ™ endometrial ablation systems are effective in reducing menstrual loss in women with DUB and achieve high rates of patient satisfaction. The Novasure ™ system achieved a statistically significantly higher rate of amenorrhea in this study. Cavaterm 3.1 the all new third generation of endometrial ablation technique consists of an adjustable, soft silicone flexible balloon and the Central Control Unit. Cavaterm 3.1 treatment combines heat and pressure during a total treatment time of 10 minutes that irreversibly coagulate the endometrium and underlying myometrium to a depth of 5-8 mm.

Endometrial ablation by one of four methods: Cavaterm, endometrial laser interstitial thermotherapy (ELITT), endometrial laser ablation (ELA), or NovaSure impedance-controlled system.

3.1 Second-generation EA techniques have been introduced with the aim of providing simpler, quicker and more effective treatment options for HMB compared with first-generation EA techniques and hysterectomy. These techniques are less operator-dependent than the first-generation techniques, but they rely heavily on the devices themselves to ensure safety and efficacy. 2003-04-01 2005-11-01 Abstract. Fifty patients due to undergo endometrial ablation as a treatment of dysfunctional uterine bleeding were recruited to assess the efficacy and safety of a new thermal balloon ablation system (Cavaterm).

Thermal balloon endometrial ablation: a systematic review. Archives of Gynecology and Obstetrics, 2008. Christos Iavazzo

George Vorgias. Christos Iavazzo. George Vorgias. Download PDF. Download Full PDF Package. This paper.

Adult; Catheter Ablation/adverse effects; Catheter Ablation/methods* To compare two second-generation endometrial ablation systems in women with dysfunctional uterine bleeding (DUB) who want conservative surgical treatment.
Vad påverkar räntabilitet på totalt kapital

The procedure does not require additional training and expertise in operative hysteroscopy and compares favourably with established techniques. PMID: 12623485 [PubMed - indexed for MEDLINE] MeSH Terms.

Cavaterm was an acceptable procedure and The objective of this prospective study was to evaluate the effectiveness of day-case Cavaterm plus thermal balloon endometrial ablation in the treatment of therapy-resistant menorrhagia. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd: YAG laser for the treatment of dysfunctional uterine bleeding.
Vardcentralen hogdalen

nordea liv & pension sverige
asiatisk livsmedel norrköping
skattepengene kommer ikke
mobergs soldat
om man blir sjukskriven när man är arbetslös

Cavaterm™ is a minimally invasive treatment for Dysfunctional Uterine Bleeding (DUB) This second generation endometrial ablation technique consists of an adjustable, flexible silicone balloon catheter and a Cavabox. The treatment combines heat and pressure during 10 minutes to irreversibly coagulate the endometrium and underlying myometrium to a

Fifty patients due to undergo endometrial ablation as a treatment of dysfunctional uterine bleeding were recruited to assess the efficacy and safety of a new thermal balloon ablation system (Cavaterm). The patients were followed up for a mean of 14 months (range 6–24): 34 (68%) have complete amen‐orrhoea, 12 (24%) only have spotting, two Although these preliminary results are encouraging, all patients remain under review to determine long term effect of the procedure. Further evaluation is also underway in the form of a randomised trial against endometrial laser ablation. PMID: 10549958 [Indexed for MEDLINE] MeSH terms.